Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Clinical trial NCT01972529 · COMPLETED

Trial details

NCT number: NCT01972529
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocytopenia Associated With Liver Disease

Start date: 2014-02-01
Primary completion: 2017-01-26
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.